EA201790899A1 - Состав, содержащий спирулину и пальмитоилэтаноламид и/или их соли или их фармацевтически приемлемые производные и препараты из них, для применения в профилактике и/или лечении состояний гиперактивированных тканей - Google Patents
Состав, содержащий спирулину и пальмитоилэтаноламид и/или их соли или их фармацевтически приемлемые производные и препараты из них, для применения в профилактике и/или лечении состояний гиперактивированных тканейInfo
- Publication number
- EA201790899A1 EA201790899A1 EA201790899A EA201790899A EA201790899A1 EA 201790899 A1 EA201790899 A1 EA 201790899A1 EA 201790899 A EA201790899 A EA 201790899A EA 201790899 A EA201790899 A EA 201790899A EA 201790899 A1 EA201790899 A1 EA 201790899A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- prevention
- changes
- applications
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Заявленное изобретение относится к составу, содержащему спирулину и пальмитоилэтаноламид (ПЭА) и/или их фармацевтически приемлемые производные или соли, фармацевтическим препаратам, содержащим сочетание спирулины и ПЭА и/или их фармацевтически приемлемые производные или соли, в некоторых случаях, с как минимум одним физиологически приемлемым эксципиентом, и применению сочетания спирулины и ПЭА и/или их фармацевтически приемлемых производных или солей и фармацевтических препаратов, содержащих данное сочетание, в профилактике и/или лечении синдрома гиперактивированных тканей, в профилактике и/или лечении воспалительных патологий, в профилактике и/или лечении изменений коронарной и/или кардиальной тканей, в профилактике и/или лечении изменений сосудистой ткани, в профилактике и/или лечении изменений офтальмологических патологий, предпочтительно в профилактике и/или лечении изменений патологий, связанных с возрастной макулярной дегенерацией и глаукомой, в профилактике и/или лечении дислипидемии, в профилактике и/или лечении изменений легочной ткани, в профилактике и/или лечении изменений тазовых тканей, в профилактике и/или лечении клеточных изменений вследствие карциногенеза, и/или в профилактике и/или лечении дерматологических изменений.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20141825 | 2014-10-22 | ||
| PCT/IB2015/058074 WO2016063217A1 (en) | 2014-10-22 | 2015-10-20 | Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201790899A1 true EA201790899A1 (ru) | 2017-09-29 |
| EA038593B1 EA038593B1 (ru) | 2021-09-21 |
Family
ID=51951920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201790899A EA038593B1 (ru) | 2014-10-22 | 2015-10-20 | Состав, содержащий спирулину и пальмитоилэтаноламид и/или их фармацевтически приемлемые соли, и его применение в профилактике и лечении состояний гиперактивированных тканей |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10646523B2 (ru) |
| EP (1) | EP3215143B1 (ru) |
| CA (1) | CA2964858C (ru) |
| DK (1) | DK3215143T3 (ru) |
| EA (1) | EA038593B1 (ru) |
| ES (1) | ES2886081T3 (ru) |
| HK (1) | HK1243327A1 (ru) |
| LT (1) | LT3215143T (ru) |
| MA (1) | MA40847A (ru) |
| PL (1) | PL3215143T3 (ru) |
| PT (1) | PT3215143T (ru) |
| WO (1) | WO2016063217A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201807034XA (en) | 2017-09-05 | 2019-04-29 | Frimline Private Ltd | A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease |
| IT202000013156A1 (it) * | 2020-06-03 | 2021-12-03 | Welifepharma Sagl | Composizione oftalmica liquida comprendente un estratto acquoso di spirulina platensis. |
| EP3991726A1 (en) * | 2020-11-02 | 2022-05-04 | Kura Srl | Anti-inflammatory composition comprising palmitoylethanolamide and phycocyanin |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE386056T1 (de) * | 2000-07-05 | 2008-03-15 | Bergter Wolfgang Dr | Zusammensetzung für pharmaka und kosmetika |
| US20020120242A1 (en) * | 2000-12-22 | 2002-08-29 | Tyrrell David John | Absorbent articles with hydrophilic compositions containing botanicals |
| WO2004045307A2 (en) * | 2002-11-18 | 2004-06-03 | Natural Asa | Dietry supplements and foods product comprising oleylethanolamide |
| US20040258740A1 (en) * | 2003-04-10 | 2004-12-23 | Nene Labs | Transdermal delivery composition |
| MA29706B1 (fr) * | 2007-02-14 | 2008-09-01 | Philippe Alleon | Complement alimentaire comprenant de la spiruline et un produit a base de plante du genre aloe, et son utilisation cosmetique |
| US20080199489A1 (en) * | 2007-02-16 | 2008-08-21 | Parrinello Vincene M | Skin treatment formulations and method |
| JP4803091B2 (ja) | 2007-03-30 | 2011-10-26 | コニカミノルタビジネステクノロジーズ株式会社 | 画像形成装置 |
| TW200841883A (en) * | 2007-04-20 | 2008-11-01 | Microbio Company Ltd Taiwan | Composition for prevention and/or treatment of cancer |
| WO2009088433A1 (en) * | 2008-01-04 | 2009-07-16 | Nestec S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions |
| EP2444078B1 (en) * | 2010-10-04 | 2017-09-13 | EPITECH GROUP S.p.A. | Use of amides of mono and dicarboxylic acids in the treatment of renal diseases |
| US20120107300A1 (en) * | 2010-11-01 | 2012-05-03 | Jeffrey Nathan Schirripa | Cannabinoid Compositions and Methods |
| KR101408568B1 (ko) * | 2012-06-05 | 2014-06-17 | (주)하이모 | 황국균 및 유산균 복합발효기술을 이용한 발효효소식품의 제조 방법 |
| NL2011448C2 (en) | 2012-09-17 | 2015-01-29 | Jp Russell Science Holding Ltd | Pharmaceutical or neutraceutical composition comprising palmitoylethanolamide particles. |
| CN103156108B (zh) * | 2013-04-02 | 2015-03-18 | 曾晓飞 | 一种防治糖尿病高血压病症的强化食品 |
-
2015
- 2015-10-20 WO PCT/IB2015/058074 patent/WO2016063217A1/en active Application Filing
- 2015-10-20 ES ES15797430T patent/ES2886081T3/es active Active
- 2015-10-20 PT PT157974304T patent/PT3215143T/pt unknown
- 2015-10-20 US US15/519,611 patent/US10646523B2/en active Active
- 2015-10-20 CA CA2964858A patent/CA2964858C/en active Active
- 2015-10-20 EP EP15797430.4A patent/EP3215143B1/en active Active
- 2015-10-20 DK DK15797430.4T patent/DK3215143T3/da active
- 2015-10-20 PL PL15797430T patent/PL3215143T3/pl unknown
- 2015-10-20 EA EA201790899A patent/EA038593B1/ru unknown
- 2015-10-20 MA MA040847A patent/MA40847A/fr unknown
- 2015-10-20 LT LTEPPCT/IB2015/058074T patent/LT3215143T/lt unknown
-
2018
- 2018-02-27 HK HK18102792.6A patent/HK1243327A1/zh unknown
-
2020
- 2020-04-01 US US16/837,333 patent/US11311581B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11311581B2 (en) | 2022-04-26 |
| US20170246227A1 (en) | 2017-08-31 |
| DK3215143T3 (da) | 2021-09-20 |
| EP3215143B1 (en) | 2021-07-21 |
| PT3215143T (pt) | 2021-08-31 |
| EA038593B1 (ru) | 2021-09-21 |
| MA40847A (fr) | 2017-09-13 |
| PL3215143T3 (pl) | 2021-11-08 |
| LT3215143T (lt) | 2021-10-25 |
| WO2016063217A1 (en) | 2016-04-28 |
| CA2964858A1 (en) | 2016-04-28 |
| HK1243327A1 (zh) | 2018-07-13 |
| EP3215143A1 (en) | 2017-09-13 |
| CA2964858C (en) | 2023-10-24 |
| US10646523B2 (en) | 2020-05-12 |
| ES2886081T3 (es) | 2021-12-16 |
| US20200222476A1 (en) | 2020-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124432T1 (el) | Φαρμακευτικες συνθεσεις που αποτελουν ν-(3,5-διμεθοδυφαινυλ)-ν'-(1-μεθυλαιθυλ)-ν-[3-(1--μεθυλ-1η-πυραζολ-4-υλ)κινοοξαλιν-6-υλ]αιθανο-1,2-διαμινη | |
| EA201892395A1 (ru) | Лекарственные составы ингибитора lsd1 | |
| MX2020010484A (es) | Derivados de heterociclilos sustituidos como inhibidores de cdk. | |
| PH12016501394A1 (en) | Compounds for treating patients with ros1 mutant cancer cells | |
| TR201901312T4 (tr) | Mcl-1 proteinini inhibe eden tetrahidronaftalen türevleri. | |
| NZ735575A (en) | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use | |
| CL2015002835A1 (es) | Nuevos derivados de piridina | |
| AU2014375637A1 (en) | Formula of neuregulin preparation | |
| MX2021006884A (es) | Compuestos y su uso para el tratamiento de la deficiencia de alfa1-antitripsina. | |
| BR112017011552A2 (pt) | derivados de fgf21 e seu uso | |
| PH12017500977A1 (en) | 1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4h-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidase | |
| BR112017006842A2 (pt) | formulação de rapamicina inalável para o tratamento de hipertensão pulmonar | |
| CO2018001359A2 (es) | Derivados del ácido 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| WO2016029136A8 (en) | 3-amidobenzamides and uses thereof for increasing cellular levels of a3g | |
| MX2017004760A (es) | Formulacion esterilizada por calor que comprende quitosan y proceso para preparacion de la misma. | |
| EA201790899A1 (ru) | Состав, содержащий спирулину и пальмитоилэтаноламид и/или их соли или их фармацевтически приемлемые производные и препараты из них, для применения в профилактике и/или лечении состояний гиперактивированных тканей | |
| BR112017023762A2 (pt) | formulações de depósito injetáveis | |
| MX357888B (es) | Sales basicas de adicion de nitroxolina y usos de las mismas. | |
| WO2015048188A8 (en) | Modified fibroblast growth factors for the treatment of ocular disorders | |
| BR112017027285A2 (pt) | ?cocristal, composição farmacêutica e método para o tratamento de uma doença? | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| BR112017007095A2 (pt) | conjugados e derivados de prostaglandina para tratamento de glaucoma e hipertensão ocular | |
| BR112018008769A2 (pt) | formulações farmacêuticas, formulações líquidas aquosa reconstituída e liofilizada, seringa, método de fabricação de uma formulação farmacêutica, método para tratamento de uma doença e uso de uma formulação reconstruída | |
| MX2018012952A (es) | Composicion oftalmica que comprende una combinacion sinergica de glucogeno y acido hialuronico o sal del mismo. | |
| EA201990834A1 (ru) | Пиримидиновые пролекарства для лечения вирусных инфекций и других заболеваний |